Our life sciences advisory experts are ready to steer you through the maze of technologies and compliance regulations to develop successful enterprise and digital solutions that best fit your strategic goals and needs of patients. We have expertise in:
With ISG’s life sciences consultants, you can identify opportunities for cost optimization and service quality improvement, design a roadmap to achieve excellence, and establish a platform for substantial and sustained results
ISG is a leader in proprietary research, advisory consulting and executive event services focused on market trends and disruptive technologies.
Get the insight and guidance you need to accelerate growth and create more value.
Learn MoreFor firms in the life sciences and healthcare analytics sector, leveraging advanced analytics has become crucial to remain competitive. The rapid advancements in AI and Generative AI (GenAI) across industries promise quick and informed decision-making by understanding user pain points and providing customized solutions to an organization’s unique problems. Implementing a modern data strategy coupled with advanced analytics and AI is a key factor in this transformation.
The clinical trials landscape is undergoing a significant transformation with the rise of decentralized trial methodologies. A growing recognition of the limitations of traditional trial approaches, such as centralized site-based monitoring and patient visits, drives this shift. Decentralized trials offer a promising alternative by leveraging digital technologies to conduct certain trial activities remotely, including patient recruitment, consent, data collection and monitoring. This approach enhances patient convenience and participation and enables real-time data collection and analysis, leading to more efficient and cost-effective trials.
In the past year, as the world continued to recover from the challenges and restrictions implemented to manage the COVID-19 situation, leading life science companies and the providers that support them made significant advances in incorporating technology solutions into the DNA of their operations. This sector has historically been reluctant to embrace innovative approaches at scale, but the pandemic has catalyzed a permanent change. For starters, the pandemic made many formerly standard processes, such as in-person patient visits and justin- time supply chain practices impossible, which created an unprecedented demand for innovative solutions. Leading solution providers not only intervened with existing technology solutions but also demonstrated their readiness to collaborate, innovate and invest with greater flexibility and customer-centric focus than ever before.
